Pathogenesis of glomerulonephritis.
This review summarizes current understanding of the mechanisms which mediate immune glomerular injury in glomerulonephritis. Non-inflammatory lesions resembling minimal change disease and membranous nephropathy, respectively, are induced by non-complement fixing antibodies to glomerular epithelial cell (GEC) membrane antigens (minimal change disease) and GEC membrane insertion of the C5b-9 membrane attack complex of complement (membranous nephropathy). The cellular mechanisms of these effects are unclear but may involve GEC activation and release of local mediators, such as proteases or oxidants, or GEC detachment from underlying basement membrane. Inflammatory types of glomerular lesions are mediated by circulating inflammatory cells (neutrophils, platelets, macrophages) or by resident glomerular cells (mesangial cells) or both. Neutrophil-mediated injury involves local release of GBM degrading proteases or GBM halogenation induced by the interaction of neutrophil-derived myeloperoxidase with H2O2 and a halide. Neutrophil induced glomerular injury is augmented by platelets. Recent evidence establishes that mesangial cell proliferation in glomerulonephritis is mediated by complement and platelets. Mesangial cell proliferation is accompanied by increased expression of PDGF and PDGF receptor proteins and the genes for these proteins resulting in an autocrine mechanism of cell proliferation. Mesangial cell proliferation is also accompanied by increased release of neutral proteinase in sites of basement membrane damage. Mesangial cell proliferation precedes up-regulation of genes for extracellular matrix components in several models and may be important in the pathogenesis of glomerulosclerosis.
Couser
W G
WG
Department of Medicine, University of Washington School of Medicine, Seattle.
D000818:Animals; D001323:Autoantibodies / Q000378:metabolism; D001485:Basement Membrane / Q000276:immunology; D001792:Blood Platelets / Q000502:physiology; D015938:Complement Membrane Attack Complex / Q000378:metabolism; D005920:Glomerular Mesangium / Q000502:physiology; D005921:Glomerulonephritis / Q000209:etiology*; D006801:Humans; D007678:Kidney Glomerulus / Q000276:immunology / Q000293:injuries; D007962:Leukocytes / Q000502:physiology; D008264:Macrophages / Q000502:physiology
D001323:Autoantibodies; D015938:Complement Membrane Attack Complex